Market Report, "Oman Pharmaceuticals & Healthcare Report Q4 2010", published

Oct. 4, 2010 - PRLog -- BMI considers Oman's pharmaceutical market to be relatively attractive to multinational pharmaceutical companies operating in the Middle East. Valued at OMR127mn (US$331mn) in 2009, drug sales have risen strongly in recent years on the back of strong economic performance - a result of energy driven wealth.

Per-capita expenditure on pharmaceuticals reached a value of US$116 in 2009 and is likely to top US$242 by 2014, a level comparable with more developed emerging markets, but still behind those in much of Western Europe and North America at present. Despite the country being receptive to foreign-made and novel pharmaceuticals, strict price controls are one of the main factors for this situation.

Oman's economic growth outlook remains positive, thanks to strong government spending growth, rising export volumes and an improving investment picture. That said, domestic demand is proving slow to recover, meaning that Oman could prove vulnerable to any worsening of the global picture. Nevertheless, BMI forecasts continued double-digit annual growth in pharmaceutical sales over the next five years. This will be supported by a changing epidemiological profile and greater access to advanced treatments.

The government is also becoming more active in supporting health initiatives such as immunisations. The health ministry is exploring the possibility of including more vaccines in its Expanded Programme of Immunisation (EPI). One recent addition was the 13-valent polysaccharide conjugate vaccine (PCV 13), Prevnar 13, in May 2010.

Oman has embarked upon a series of reforms to boost its local drug industry. The government was active in the creation of one pharmaceutical concern (namely National Pharmaceutical Industries (NPI)), in a bid to lower its reliance on US and European imports, as well as generic brands more recently sourced from other Gulf countries such as Egypt, Jordan and India.

Around half of all Omani exports go to Syria and various EU countries. Exports are predominately made up of pharmaceutical raw materials. The attempts by the Omani government to diversify its economy away from oil could see an increased focus on the drug sector, although exports remain minimal at present. Oman Pharmaceutical Products (OPP)'s US FDA approval for one of its antibiotic products should help drive exports, although it is likely that exports within the region will be a more sustainable source of long-term growth for the domestic sector.

For more information or to purchase this report, go to:
-  http://www.fastmr.com/prod/87254_oman_pharmaceuticals_hea...

Report Table of Contents:

Executive Summary
SWOT Analysis
- Oman Pharmaceuticals And Healthcare Industry SWOT
- Oman Political SWOT Industry SWOT
- Oman Economic SWOT
- Oman Business Environment SWOT
Pharmaceutical Business Environment Ratings
- Table: Middle East And Africa (MEA) - Regional Pharmaceutical Business Environment Ratings, Q410
- Rewards
- Risks
Oman - Market Summary
Regulatory Regime
- Recent Regulatory Developments
- Intellectual Property Regime
- Table: Current IP Laws In Oman
- Pricing And Reimbursement
- Regional Price Harmonisation
- Pharmaceutical Industry Developments
- Free Trade Agreements
Industry Developments
- Epidemiology
- Table: Oman Mortality Indicators, 2006
- Healthcare Sector
- Table: Number Of Health Centres In Oman, By Region
- Table: Number And Type Of Health Institutions In Oman
- Private Healthcare Sector
- Healthcare Funding
- Healthcare Reforms
- Table: Healthcare Reform Targets
- Medical Tourism
- International Healthcare Collaboration
- International Pharmaceutical Collaboration
- Research And Biotechnology
Industry Forecast Scenario
- Overall Market Forecasts
- Key Growth Factors - Industry
- Key Growth Factors - Macroeconomic
- Table: Oman - Economic Activity
- Prescription Drug Market Forecast
- Patented Drug Market Forecast
- Generic Drug Market Forecast
- OTC Medicine Market Forecast
- Pharmaceutical Trade Forecast
- Medical Device Market Forecast
- Other Healthcare Data Forecasts
- Key Risk To BMI's Forecasts
Competitive Landscape
- Pharmaceutical Sector
- Table: Registered Pharmaceutical Companies And Products
- Domestic Industry
- Foreign Industry
Company Monitor
- Indigenous Manufacturers
- Zynova/Oman Pharmaceutical Products (OPP)
- National Pharmaceutical Industries (NPI)
- Multinationals
- Novartis
- Johnson & Johnson
Country Snapshot: Oman Demographic Data
- Section 1: Population
- Table: Demographic Indicators, 2005-2030
- Table: Rural/Urban Breakdown, 2005-2030
- Section 2: Education And Healthcare
- Table: Education, 2002-2005
- Table: Vital Statistics, 2005-2030
- Section 3: Labour Market And Spending Power
- Table: Employment Indicators, 1999-2004
- Table: Consumer Expenditure, 2000-2012 (US$)
BMI Methodology
- How We Generate Our Pharmaceutical Industry Forecasts
- Pharmaceuticals Business Environment Ratings
- Risk/Reward Ratings Methodology
- Ratings Overview
- Table: Pharmaceutical Business Environment Indicators
- Weighting
- Table: Weighting Of Components
- Sources
Forecast Tables

About Business Monitor International

Business Monitor International (BMI) offers a comprehensive range of products and services designed to help senior executives, analysts and researchers assess and better manage operating risks, and exploit business opportunities, across 175 markets.  BMI offers three main areas of expertise: Country Risk BMI's country risk and macroeconomic forecast portfolio includes weekly financial market reports, monthly regional Monitors, and in-depth quarterly Business Forecast Reports.  Industry Analysis BMI covers a total of 17 industry verticals through a portfolio of services, including in-depth quarterly Country Forecast Reports.  View more research from Business Monitor International at http://www.fastmr.com/catalog/publishers.aspx?pubid=1010

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

# # #

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.